Fresenius will distribute Genzyme's Sepra products in select European markets Feb. 17, 1999 No Comments
Human Genome Sciences initiates phase II clinical trials of new wound-healing agent Feb. 15, 1999 No Comments
Schering discloses new leukotriene antagonists particularly useful as dermatological products Feb. 3, 1999 No Comments
RSS